BARRETT EVANS

Insider Reports History

Signature
Barrett Evans
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by BARRETT EVANS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Common Stock 16,233 $67,204 $4.14 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
APPlife Digital Solutions Inc CFO, Director, 10%+ Owner Common Stock 500,000,000 13 Jun 2025 These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member.
APPlife Digital Solutions Inc CFO, Director, 10%+ Owner Common Stock 50,000,000 13 Jun 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
BLOOMIOS, INC. Pres, Chief Strategy Officer, Director, 10%+ Owner Common Stock 2,586,052 09 Jul 2021 By AGPL
BLOOMIOS, INC. Pres, Chief Strategy Officer, Director, 10%+ Owner Common Stock 1,263,125 09 Jul 2021 By MCC
BLOOMIOS, INC. Pres, Chief Strategy Officer, Director, 10%+ Owner Common Stock 250,000 09 Jul 2021 By CE
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Preferred Stock Series C-1 131,034 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
BLOOMIOS, INC. Pres, Chief Strategy Officer, Director, 10%+ Owner Common Stock 100,000 09 Jul 2021 By TSP
BLOOMIOS, INC. Pres, Chief Strategy Officer, Director, 10%+ Owner Common Stock 25,000 09 Jul 2021 By BSRS
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Preferred Stock Series D 4,498 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
APPlife Digital Solutions Inc CFO, Director, 10%+ Owner Preferred Stock Series C 1,250 13 Jun 2025 These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member.
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Preferred Stock Series D 1,000 15 May 2025 Direct
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Preferred Stock Series D 1,000 15 May 2025 These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member.
Protagenic Therapeutics, Inc.\new ex CEO, Director, 10%+ Owner Preferred Stock Series C 787 15 May 2025 These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.

Insider Reports Filed by BARRETT EVANS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALDS APPlife Digital Solutions Inc 13 Jun 2025 0 $0 3 CFO, Director, 10%+ Owner 24 Oct 2025, 13:34
PTIX Protagenic Therapeutics, Inc.\new 15 May 2025 0 $0 3 ex CEO, Director, 10%+ Owner 24 Oct 2025, 13:40
BLMS BLOOMIOS, INC. 09 Jul 2021 0 $0 3 Pres, Chief Strategy Officer, Director, 10%+ Owner 11 Aug 2021, 13:34